Eric Pottier
Keine laufenden Positionen mehr
Karriereverlauf von Eric Pottier
Ehemalige bekannte Positionen von Eric Pottier
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TXCELL | Geschäftsführer | 22.01.2013 | 01.01.2014 |
Corporate Officer/Principal | 01.01.2014 | 01.03.2016 | |
Eurand SpA
Eurand SpA Pharmaceuticals: MajorHealth Technology Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy. | Corporate Officer/Principal | - | - |
Ausbildung von Eric Pottier
L'Université d'Angers | Doctorate Degree |
Statistik
International
Frankreich | 3 |
Italien | 2 |
Operativ
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Sangamo Therapeutics France SAS
Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Eurand SpA
Eurand SpA Pharmaceuticals: MajorHealth Technology Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy. | Health Technology |
- Börse
- Insiders
- Eric Pottier
- Erfahrung